All In Biotech

Drug Trial Radar · NCT00004399

Randomized Study of Nimodipine Versus Magnesium Sulfate in the Prevention of Eclamptic Seizures in Patients With Severe Preeclampsia

Last checked: Nov 19, 2026Latest source record: Mar 25, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 2,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,000

Actual

Start

Sep 1995

Primary completion

Not stated

Study completion Aug 2000

Sponsor

Sponsor type
Federal agency
Collaborators
University of Utah
First posted
Oct 19, 1999

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Primary purpose
Prevention
Who can join
Female only
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

OBJECTIVES: I. Determine the effectiveness of nimodipine versus magnesium sulfate in the prevention of eclamptic seizures in patients with severe preeclampsia.

Conditions

  • Pre-eclampsia

Interventions

  • magnesium sulfateDrug

  • nimodipineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.